All In Biotech

Drug Trial Radar · NCT05667493

An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

An Open-Label Extension Study to Assess the Long-Term Safety of Eplontersen (ION-682884) in Patients With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Last checked: Nov 20, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

1,400

Planned (sponsor's estimate)

Start

Nov 30, 2022

Primary completion

Aug 2029

Study completion Aug 2029

Sponsor

Lead sponsor
Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
Sponsor type
Industry
Collaborators
AstraZeneca
First posted
Dec 28, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and tolerability of extended dosing with eplontersen in participants with ATTR-CM.

Conditions

  • Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Interventions

  • EplontersenDrug

    Eplontersen will be administered by SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)Time frame: Baseline up to 36 months
  2. Change From Baseline in Platelet CountTime frame: Baseline up to 36 months
  3. Change From Baseline in Estimated Glomerular Filtration Rate (eGFR)Time frame: Baseline up to 36 months
  4. Change From Baseline in Urine Protein Creatinine Ratio (UPCR)Time frame: Baseline up to 36 months

Locations

134 sites in 20 countries. Site status is shown where the registry gives one.

  • Mayo Clinic

    Scottsdale, Arizona

  • Cedars-Sinai Medical Center

    Beverly Hills, California

  • Altman Clinical and Translational Research Institute - Center for Clinical Research

    La Jolla, California

  • University Of California San Francisco Urology Practice

    San Francisco, California

  • Stanford University (Leland Stanford Junior University)

    Stanford, California

  • University of Colorado Hospital - Anschutz Medical Campus

    Aurora, Colorado

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia

  • The George Washington Medical Faculty Associates - Foggy Bottom North Pavilion

    Washington D.C., District of Columbia

  • Cleveland Clinic Florida

    Weston, Florida

  • Piedmont Heart of Fayetteville

    Atlanta, Georgia

  • Emory Heart and Vascular Center - Emory Clifton Campus

    Atlanta, Georgia

  • Piedmont Atlanta Hospital

    Fayetteville, Georgia

  • Northwestern University

    Chicago, Illinois

  • Loyola University Medical Center

    Maywood, Illinois

  • Indiana University Health University Hospital

    Indianapolis, Indiana

  • University of Kansas Medical Center (KUMC)

    Kansas City, Kansas

  • University of Kansas Medical Center

    Kansas City, Kansas

  • University of Maryland Medical Center

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • Boston University School of Medicine

    Boston, Massachusetts

  • Henry Ford Health System

    Detroit, Michigan

  • Allina Health Minneapolis Heart Institute - Abbott Northwestern's Heart Hospital

    Minneapolis, Minnesota

  • Mayo Clinic

    Rochester, Minnesota

  • Saint Luke's Hospital of Kansas City

    Kansas City, Missouri

  • Barnes-Jewish Hospital

    St Louis, Missouri

  • New York University Langone Cardiology Associates

    New York, New York

  • Weill Cornell Medicine Cardiology

    New York, New York

  • Columbia University Irving Medical Center

    New York, New York

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • Duke University Medical Center

    Durham, North Carolina

  • Carl and Edyth Lindner Research Center at The Christ Hospital

    Cincinnati, Ohio

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • Cleveland Clinic Main Campus

    Cleveland, Ohio

  • The Ohio State University College of Medicine

    Columbus, Ohio

  • Oregon Health and Science University

    Portland, Oregon

  • Lancaster General Hospital

    Lancaster, Pennsylvania

  • Penn Presbyterian Medical Center

    Philadelphia, Pennsylvania

  • Medical University of South Carolina

    Charleston, South Carolina

  • Vanderbilt Heart and Vascular Institute

    Nashville, Tennessee

Showing 40 of 134 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.